Array Biopharma To Present At The Goldman Sachs 38th Annual Global Healthcare Conference - Array Technologies (NASDAQ:ARRY)

BOULDER, Colo., June 1, 2017 /PRNewswire/ -- Array BioPharma Inc. ARRY today announced that its Chief Operating Officer, Andy Robbins, will present at the Goldman Sachs 38th Annual Global Healthcare Conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

Event:	Goldman Sachs 38th Annual Global Healthcare Conference
Presenter:	Andy Robbins, Chief Operating Officer
Date:	Tuesday, June 13, 2017
Time:	10:00 a.m. Pacific Time
Webcast:	https://cc.talkpoint.com/gold006/061317a_as/?entity=52_O16UKUL

Array BioPharma. (PRNewsFoto/Array BioPharma Inc.) (PRNewsFoto/)

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Array-owned or partnered drugs are advancing in registration studies: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), larotrectinib (partnered with Loxo Oncology), tucatinib (partnered with Cascadian Therapeutics) and ipatasertib (partnered with Roche).

CONTACT:	Tricia Haugeto
	Array BioPharma Inc.
	303-386-1193
	thaugeto@arraybiopharma.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-goldman-sachs-38th-annual-global-healthcare-conference-300466999.html

SOURCE Array BioPharma Inc.

Market News and Data brought to you by Benzinga APIs